• 3834 Citations
  • 24 h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Deborah Toppmeyer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    • 3834 Citations
    • 24 h-Index
    • 54 Article
    • 8 Review article
    • 1 Editorial
    • 1 Letter

    5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial

    Poppe, M. M., Yehia, Z. A., Baker, C., Goyal, S., Toppmeyer, D., Kirstein, L., Chen, C., Moore, D. F., Haffty, B. G. & Khan, A. J., Jul 15 2020, In : International Journal of Radiation Oncology Biology Physics. 107, 4, p. 694-700 7 p.

    Research output: Contribution to journalArticle

  • Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

    Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F. & 9 others, Dees, E. C., Geyer, C. E., Olson, J. A., Wood, W. C., Lively, T., Paik, S., Ellis, M. J., Abrams, J. & Sledge, G. W., Mar 2020, In : JAMA Oncology. 6, 3, p. 367-374 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 14 Scopus citations

    Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

    Sharma, M. R., Mehrotra, S., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno-Aspitia, A., Lad, T. E., Velasco, M., Overmoyer, B., Rugo, H. S., Ratain, M. J. & Gobburu, J. V., Apr 1 2020, In : Journal of Clinical Pharmacology. 60, 4, p. 444-452 9 p.

    Research output: Contribution to journalArticle

  • TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

    Tung, N., Arun, B., Hacker, M. R., Hofstatter, E., Toppmeyer, D. L., Isakoff, S. J., Borges, V., Legare, R. D., Isaacs, C., Wolff, A. C., Marcom, P. K., Mayer, E. L., Lange, P. B., Goss, A. J., Jenkins, C., Krop, I. E., Winer, E. P., Schnitt, S. J. & Garber, J. E., May 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1539-1548 10 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy

    Sayan, M., Vergalasova, I., Jhawar, S., Kumar, S., George, M., Kowzun, M., Potdevin, L., Toppmeyer, D., Haffty, B. & Ohri, N., 2020, (Accepted/In press) In : Clinical Breast Cancer.

    Research output: Contribution to journalArticle